Panacea Biotec Share Price Surges on Securing LoA from UNICEF for Supply of Bivalent Oral Polio Vaccine

Panacea Biotec Limited has received a Letter of Award (LoA) from the United Nations International Children's Emergency Fund (UNICEF) for the supply of bivalent Oral Polio Vaccine (bOPV), as per the exchange filings. 

The award will be executed during Calendar Year 2028 under the company's existing long-term supply agreement with UNICEF.  

Order Secured Under Long-Term Agreement 

The latest award forms part of the Long-Term Agreement signed between Panacea Biotec and UNICEF. 

The company had earlier announced, on October 3, 2025, that it had secured the agreement to supply bivalent Oral Polio Vaccine to UNICEF for the period from April 1, 2026, to March 31, 2030.  

The earlier award covered 10-dose and 20-dose vaccine presentations for Q2 CY2026 and CY2027, while the new order extends supplies into Calendar Year 2028.  

Scope of the Supply 

Under the Letter of Award, Panacea Biotec will supply bivalent Oral Polio Vaccine (bOPV) in 10-dose and 20-dose presentations to UNICEF. 

The Letter of Award was received on August 4, 2026, and the contract will be executed during Calendar Year 2028. The order has been awarded by an international entity, with a total consideration of $8.205 million, equivalent to approximately ₹78.24 crore.  

Order Value Strengthens International Business 

The latest award further expands Panacea Biotec's supply commitments under its existing agreement with UNICEF and adds another international vaccine order to its order book. 

The contract value of approximately ₹78.24 crore relates exclusively to vaccine supplies scheduled for Calendar Year 2028 under the long-term arrangement.  

Read More: LIC OFS Opens for Retail Investors Today on August 5, 2026: Here's How to Subscribe! 

Panacea Biotec Share Price Performance  

As of 05 August 2026, at 10:47 AM, Panacea Biotec Limited share price was trading at ₹425.50 per share, reflecting a surge of 1.45% from the previous trading session. 

Conclusion 

With this latest UNICEF order, Panacea Biotec strengthens its long-term vaccine supply partnership, with deliveries scheduled during 2028 under the agreement that remains valid until March 2030. 

Want to read stock market updates in Hindi? Angel One News gives comprehensive share market news in Hindi.  

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.  

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.